Cargando…
Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study
Use of plasma DNA to detect mutations has spread widely as a form of liquid biopsy. EGFR T790M has been observed in half of lung cancer patients who have acquired resistance to EGFR tyrosine kinase inhibitors (EGFR‐TKI). Effectiveness of monitoring T790M via plasma DNA during treatment with EGFR‐TKI...
Autores principales: | Sueoka‐Aragane, Naoko, Katakami, Nobuyuki, Satouchi, Miyako, Yokota, Soichiro, Aoe, Keisuke, Iwanaga, Kentaro, Otsuka, Kojiro, Morita, Satoshi, Kimura, Shinya, Negoro, Shunichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768390/ https://www.ncbi.nlm.nih.gov/pubmed/26577492 http://dx.doi.org/10.1111/cas.12847 |
Ejemplares similares
-
Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?
por: Hata, Akito, et al.
Publicado: (2018) -
Absence of copy number gain of EGFR: A possible predictive marker of long‐term response to afatinib
por: Nakamura, Tomomi, et al.
Publicado: (2022) -
Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments
por: Nakashima, Chiho, et al.
Publicado: (2018) -
Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer
por: Komiya, Natsuko, et al.
Publicado: (2021) -
ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies
por: Matsumoto, Akiko, et al.
Publicado: (2021)